Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,361
Value
$676.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,361$676.1K<0.1%−463−25.4%ReducedHolders
Q1 20261,824$814.5K<0.1%−19−1.0%ReducedHolders
Q4 20251,843$835.6K<0.1%+52+2.9%AddedHolders
Q3 20251,791$701.4K<0.1%−2,327−56.5%ReducedHolders
Q2 20254,118$1.83M<0.1%−2,107−33.8%ReducedHolders
Q1 20256,225$3.02M0.1%+8+0.1%AddedHolders
Q4 20246,217$2.50M0.1%−7,470−54.6%ReducedHolders
Q3 202413,687$6.37M0.2%+3,494+34.3%AddedHolders
Q2 202410,193$4.78M0.2%−2,623−20.5%ReducedHolders
Q1 202412,816$5.36M0.2%−1,065−7.7%ReducedHolders
Q4 202313,881$5.65M0.2%−1,216−8.1%ReducedHolders
Q3 202315,097$5.25M0.2%−985−6.1%ReducedHolders
Q2 202316,082$5.66M0.2%−1,073−6.3%ReducedHolders
Q1 202317,155$5.41M0.2%+2,043+13.5%AddedHolders
Q4 202215,112$4.36M0.2%−149−1.0%ReducedHolders
Q3 202215,261$4.42M0.2%−503−3.2%ReducedHolders
Q2 202215,764$4.44M0.2%+4,750+43.1%AddedHolders
Q1 202211,014$2.87M0.1%+308+2.9%AddedHolders
Q4 202110,706$2.35M0.1%−649−5.7%ReducedHolders
Q3 202111,355$2.06M0.1%+4,113+56.8%AddedHolders
Q2 20217,242$1.46M0.1%+6,516+897.5%AddedHolders
Q1 2021726$156.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.